1. Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs
   Christopher M. Fulkerson et al, 2017, International Journal of Genomics CrossRef
2. The anti-PD-1 era — an opportunity to enhance radiotherapy for patients with bladder cancer
   Richard C. Walshaw et al, 2017, Nat Rev Urol CrossRef
3. Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
   Tahlita C.M. Zuiverloon et al, 2018, BLC CrossRef
4. How cancer cells attach to urinary bladder epithelium in vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model
   Andreja Erman et al, 2018, Histochem Cell Biol CrossRef
5. Nanotechnology and cancer: improving real-time monitoring and staging of bladder cancer with multimodal mesoporous silica nanoparticles
   Sean K Sweeney et al, 2016, Cancer Nano CrossRef
6. ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis
   Junlan Zhu et al, 2017, Molecular Therapy - Nucleic Acids CrossRef
7. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
   Doreen Huebner et al, 2017, BMC Cancer CrossRef
8. Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans
   Deborah W. Knapp et al, 2020, Front. Oncol. CrossRef
9. The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression
   Ho Kyung Seo et al, 2017, Oncotarget CrossRef
10. Expression of bladder cancer‑associated glycans in murine tumor cell lines
    Marina Albert� et al, 2019, Oncol Lett CrossRef
11. An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer
    Tomoharu Naito et al, 2019, Oncol Lett CrossRef
12. Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model
    Wagner J. Fávaro et al, 2022, Med Oncol CrossRef
13. In Situ Constructed Nano‐Drug Depots through Intracellular Hydrolytic Condensation for Chemotherapy of Bladder Cancer
    Da‐Yong Hou et al, 2022, Angew Chem Int Ed CrossRef
14. In Situ Constructed Nano‐Drug Depots through Intracellular Hydrolytic Condensation for Chemotherapy of Bladder Cancer
    Da‐Yong Hou et al, 2022, Angewandte Chemie CrossRef
15. Tumor-targeting albumin nanoparticles as an efficacious drug delivery system and potential diagnostic tool in non-muscle-invasive bladder cancer therapy
    Sneha Sree Mullapudi et al, 2022, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
16. Non-Invasive Imaging Modalities in Intravesical Murine Models of Bladder Cancer
    Sydney Relouw et al, 2023, Cancers CrossRef
17. Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans
    Wonkyung Oh et al, 2023 CrossRef
18. Evaluation of the safety and feasibility of electrochemotherapy with intravenous bleomycin as local treatment of bladder cancer in dogs
    Marcelo Monte Mor Rangel et al, 2023, Sci Rep CrossRef
19. null
    Andreja Erman et al, 2024 CrossRef
20. Circular STAG2 RNA Modulates Bladder Cancer Progression via miR-145-5p/TAGLN2 and Is Considered as a Biomarker for Recurrence
    Chris Du et al, 2024, Cancers CrossRef